Citations (15)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Manikandan Lakshmanan, Usha Bughani, Senthil Duraisamy, Manish Diwan, Sunanda Dastidar & Abhijit Ray. (2008) Molecular targeting of E3 ligases – a therapeutic approach for cancer. Expert Opinion on Therapeutic Targets 12:7, pages 855-870.
Read now
Read now
Jan Sterz, Ivana von Metzler, Jens-Claus Hahne, Britta Lamottke, Jessica Rademacher, Ulrike Heider, Evangelos Terpos & Orhan Sezer. (2008) The potential of proteasome inhibitors in cancer therapy. Expert Opinion on Investigational Drugs 17:6, pages 879-895.
Read now
Read now
Articles from other publishers (13)
Qipeng Xie, Xiaohui Hua, Chao Huang, Xin Liao, Zhongxian Tian, Jiheng Xu, Yunping Zhao, Guosong Jiang, Haishan Huang & Chuanshu Huang. (2022) SOX2 Promotes Invasion in Human Bladder Cancers through MMP2 Upregulation and FOXO1 Downregulation. International Journal of Molecular Sciences 23:20, pages 12532.
Crossref
Crossref
Ji-hong Cui & Xin Xie. (2017) UCH-L1 Expressed by Podocytes: a Potentially Therapeutic Target for Lupus Nephritis?. Inflammation 40:2, pages 657-665.
Crossref
Crossref
John Silke & Domagoj Vucic. 2014. Regulated Cell Death Part B - Necroptotic, Autophagic and other Non-apoptotic Mechanisms. Regulated Cell Death Part B - Necroptotic, Autophagic and other Non-apoptotic Mechanisms
35
65
.
Sayed Mohammad Shafiee, Atefeh Seghatoleslam, Mohsen Nikseresht, Seyed Vahid Hosseini, Mahvash Alizadeh-Naeeni, Akbar Safaei & Ali Akbar Owji. (2013) UBE2Q1 expression in human colorectal tumors and cell lines. Molecular Biology Reports 40:12, pages 7045-7051.
Crossref
Crossref
Jie Yin, Ji‐Min Zhu & Xi‐Zhong Shen. (2012) New insights into pre‐mRNA processing factor 19: A multi‐faceted protein in humans. Biology of the Cell 104:12, pages 695-705.
Crossref
Crossref
Shweta Arya, Gaurav Sharma, Preeti Gupta & Swati Tiwari. (2012) In silico analysis of ubiquitin/ubiquitin-like modifiers and their conjugating enzymes in Entamoeba species. Parasitology Research 111:1, pages 37-51.
Crossref
Crossref
Jennifer Hurst-Kennedy, Lih-Shen Chin & Lian Li. (2012) Ubiquitin C-Terminal Hydrolase L1 in Tumorigenesis. Biochemistry Research International 2012, pages 1-10.
Crossref
Crossref
Noel Ferro & Thomas Bredow. (2009) Assessment of quantum‐chemical methods for electronic properties and geometry of signaling biomolecules. Journal of Computational Chemistry 31:5, pages 1063-1079.
Crossref
Crossref
G Chen, Y Wang, M Garate, J Zhou & G Li. (2009) The tumor suppressor ING3 is degraded by SCFSkp2-mediated ubiquitin–proteasome system. Oncogene 29:10, pages 1498-1508.
Crossref
Crossref
Kerry Routenberg Love, Renuka K. Pandya, Eric Spooner & Hidde L. Ploegh. (2009) Ubiquitin C-Terminal Electrophiles Are Activity-Based Probes for Identification and Mechanistic Study of Ubiquitin Conjugating Machinery. ACS Chemical Biology 4:4, pages 275-287.
Crossref
Crossref
Cindy M. Quezada, Stuart W. Hicks, Jorge E. Galán & C. Erec Stebbins. (2009)
A family of
Salmonella
virulence factors functions as a distinct class of autoregulated E3 ubiquitin ligases
. Proceedings of the National Academy of Sciences 106:12, pages 4864-4869.
Crossref
Crossref
John W. BlankenshipEugene VarfolomeevTatiana GoncharovAnna V. FedorovaDonald S. KirkpatrickAnita Izrael-TomasevicLilian PhuDavid ArnottMariam AghajanKerry ZobelJ. Fernando BazanWayne J. FairbrotherKurt DeshayesDomagoj Vucic. (2008) Ubiquitin binding modulates IAP antagonist-stimulated proteasomal degradation of c-IAP1 and c-IAP2. Biochemical Journal 417:1, pages 149-165.
Crossref
Crossref
Xiaoli Wang, Roger A. Herr & Ted Hansen. (2008) Viral and cellular MARCH ubiquitin ligases and cancer. Seminars in Cancer Biology 18:6, pages 441-450.
Crossref
Crossref